Showing 891-900 of 987 results for "".
- 1 Million and Counting: Emsculpt Marks Treatment Milestonehttps://modernaesthetics.com/news/1-million-and-counting-emsculpt-marks-treatment-milestone/2473166/The Emsculpt family of products from BTL is the fastest aesthetic device brand to reach one million treatments, as indicated by Medical Insights. According to BTL, which reported the milestone, an average of 21 Emsculpt Classic treatments/unit a
- NeoGenesis Products Expand Beyond Oncology Skin Carehttps://modernaesthetics.com/news/neogenesis-products-expand-beyond-oncology-skin-care/2473164/NeoGenesis’ science-based skin and hair products have expanded from oncology aftercare to management of chronic skin conditions, aesthetic concerns, and wound support. The products were developed to provide a safe, natural approach to improving the quality of life of those undergoing oncolo
- FDA Tightens Breast Implant Safety Requirements, Updates Study Resultshttps://modernaesthetics.com/news/fda-tightens-breast-implant-safety-requirements-updates-study-results/2473159/FDA is calling for stronger warnings on breast implants including a boxed warning, which lists such potential risks as infection, rupture, capsular contraction, breast implant illness, and breast implant-associated anaplastic large cell Lymphoma (BIA-ALCL).
- Alastin Receives Two New Patents for Technology Related to TransFORM Body Treatmenthttps://modernaesthetics.com/news/alastin-receives-two-new-patents-for-technology-related-to-transform-body-treatment/2473148/With the issuance of two new patents from the United States Patent and Trademark Office, Alastin Skincare, Inc. now holds six patents in the US, along with a seventh patent issued in Canada. US Patent No.11,052,032 covers Alastin’s
- It’s Over: AbbVie, BTL Settle Muscle Stimulation Patent Disputehttps://modernaesthetics.com/news/its-over-abbvie-btl-settle-patent-dispute/2473143/BTL Industries has resolved its patent infringement claims against AbbVie related to BTL's muscle stimulation technology. Under the terms of the settlement agreement, AbbVie will pay BTL an undisclosed payment. The details of the agreement are confidential and will not be disc
- Alisa Lask Joins CollPlant’s Board of Directorshttps://modernaesthetics.com/news/alisa-lask-joins-collplants-board-of-directors/2473137/Industry vet Alisa Lask is now a member of CollPlant’s Board of Directors. Ms. Lask is based in the United States and has held leadership roles in medical aesthetics at both Galderma and Allergan. She will be the seventh independent member of the CollPlan
- Study Tracks Increased Sadness, Fear, Disgust Among Healthcare Workers Linked to COVID-19https://modernaesthetics.com/news/study-tracks-increased-sadness-fear-disgust-among-healthcare-workers-linked-to-covid-19/2473134/Researchers discovered patterns of significantly decreased joy, increased sadness, fear and disgust among health care professionals (HCP) during the COVID-19 pandemic. The study, led by researchers at Ben-Gurion University of the
- Elite World Group Taps Elysium Health to Develop Science-First Skincare Linehttps://modernaesthetics.com/news/elite-world-group-taps-leading-elysium-health-to-develop-science-first-skincare-line/2473133/Elysium Health, Inc. is joining forces with Elite World Group to develop a line of skincare products. Launching in spring 2022, the line is currently in development and will be sold under an independent trademark. Elite World Group's talent media network, paired wit
- Galderma Scores FDA Nod for New Cheek Fillerhttps://modernaesthetics.com/news/galderma-scores-fda-nod-for-new-cheek-filler/2473120/The U.S. Food and Drug Administration (FDA) approved Galderma’s Restylane Contour for cheek augmentation and correction of midface contour deficiencies in adults over the age of 21. Restylane Contour, a new hyaluronic acid (HA) dermal filler, is Galde
- Price Transparency Webinar Goes Live on Thursday from BuildMyBod Healthhttps://modernaesthetics.com/news/price-transparency-webinar-goes-live-on-thursday-from-buildmybod-health/2473119/A webinar planned this week with Jonathan Kaplan, MD, founder of BuildMyBod Health, will help aesthetic physicians understand the role of automated cosmetic and insurance-based price listing on a practice website. As part of the educational program scheduled June 24 at 3pm EDT, attendee